Articles dans des revues avec comité de lecture (260)
  1. 118. Bura, S. A., Castañé, A., Ledent, C., Valverde, O., & Maldonado, R. (2007). Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes. British Journal of Pharmacology, 150(6), 758-765. doi:10.1038/sj.bjp.0707152
  2. 119. Eckle, T., Krahn, T., Grenz, A., Köhler, D., Mittelbronn, M., Ledent, C., Jacobson, M. A., Osswald, H., Thompson, L. F., Unertl, K., & Eltzschig, H. K. (2007). Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation, 115(12), 1581-1590. doi:10.1161/CIRCULATIONAHA.106.669697
  3. 120. Mievis, S., Levivier, M., Communi, D., Vassart, G., Brotchi, J., Ledent, C., & Blum, D. (2007). Lack of minocycline efficiency in genetic models of Huntington's disease. Neuromolecular medicine, 9(1), 47-54. doi:10.1385/NMM:9:1:47
  4. 121. Kim, S. H., Won, S. J., Mao, X. O., Ledent, C., Jin, K., & Greenberg, D. A. (2006). Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. The Journal of pharmacology and experimental therapeutics, 319(1), 150-154. doi:10.1124/jpet.106.107698
  5. 122. Tam, J., Ofek, O., Fride, E., Ledent, C., Gabet, Y., Müller, R., Zimmer, A., Mackie, K., Mechoulam, R., Shohami, E., & Bab, I. (2006). Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Molecular pharmacology, 70(3), 786-792. doi:10.1124/mol.106.026435
  6. 123. Castañé, A., Soria, G., Ledent, C., Maldonado, R., & Valverde, O. (2006). Attenuation of nicotine-induced rewarding effects in A2A knockout mice. Neuropharmacology, 51(3), 631-640. doi:10.1016/j.neuropharm.2006.05.005
  7. 124. Teixeira-Clerc, F., Julien, B., Grenard, P., Tran Van Nhieu, J., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006). CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nature medicine, 12(6), 671-676. doi:10.1038/nm1421
  8. 125. Kiss, I., Oskolás, H., Tóth, R., Bouillet, P., Tóth, K., Fülöp, A., Scholtz, B., Ledent, C., Fésüs, L., & Szondy, Z. (2006). Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77. European Journal of Immunology, 36(6), 1559-1571. doi:10.1002/eji.200535334
  9. 126. Soria, G., Castañé, A., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2006). The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Biological psychiatry, 31(5), 978-987. doi:10.1038/sj.npp.1300876
  10. 127. Short, J. L., Ledent, C., Borrelli, E., Drago, J., & Lawrence, A. J. (2006). Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. Neuroscience, 139(2), 661-670. doi:10.1016/j.neuroscience.2005.12.052
  11. 128. Mikics, E., Dombi, T., Barsvári, B., Varga, B., Ledent, C., Freund, T. F., & Haller, J. (2006). The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behavioural pharmacology, 17(3), 223-230.
  12. 129. Katona, I., Urbán, G. M., Wallace, M., Ledent, C., Jung, K.-M., Piomelli, D., Mackie, K., & Freund, T. F. (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. The Journal of neuroscience, 26(21), 5628-5637. doi:10.1523/JNEUROSCI.0309-06.2006
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>